Ipson opens new Milton Park Research Centre

has announced the opening of a new "top-notch" research and development centre at Ipsome Bio Innovations in Milton Park, Oxfordshire.
the new lab will specialize in neuroscience research to help solve brain, spinal cord or neurological diseases, but also has a broader ability to study drugs for oncology and rare diseases.Ipson, which employs more than 80 locals, including 40 research scientists, on its Milton Park website, is already a "global innovation centre" and the new research centre is part of a series of investments that last year amounted to more than 12 million pounds.
He is extremely proud of Milton Park's team of highly skilled scientists and researchers who oversee industry-leading work in neuroscience," said John Chaddock, vice president of neurology and head of ipsen BioInnovatation.continued, "Over the past four years, IpsoD has invested more than 150 million pounds in three of our UK plants, most of which are designed to improve our research and development and manufacturing capabilities. Through the continued development of the Milton Park Research Facility, we are relentlessly working to identify and develop new compounds for treating diseases and improving the quality of life of our patients.
will enable scientists to better support current and future biomedical developments. ”（cyy123.com）